June 25, 2024
New eQo 1-Step ToughMix kit features a warm-start reverse transcriptase in a single-tube master mix format that is conveniently shipped, stored and set up at room temperature BEVERLY, Mass. -- Quantabio, a leading provider of robust DNA and RNA amplification reagents for the most demanding molecular testing and life science research applications, today announced the [...]
June 25, 2024
Porton Advanced recently introduced the MaxCyte cGMP-grade ExPERT GTx Flow Electroporation instrument to its cell therapy platform, marking the company as the first cell therapy CDMO in China to possess this clinical-grade flow electroporation system. This equipment, known for its exceptional high transfection efficiency and cell viability, is capable of handling flexible transfection volumes and [...]
ZEISS invests in Taiwan with the opening of the new Hsinchu Innovation Center
June 25, 2024
Enhancing semiconductor R&D collaboration and leveraging local engineering talent in Taiwan Hsinchu, Taiwan | ZEISS Group -- ZEISS announced the opening of its new Innovation Center in Hsinchu Science Park, Taiwan, last week. The new ZEISS Innovation Center offers a comprehensive portfolio to meet the productivity needs of semiconductor research & development (R&D), production and [...]
ERAFLASH X – THE NEXT ERA OF FLASH POINT TESTING
June 24, 2024
ERAFLASH X is the future-proof replacement for ASTM D93 Pensky-Martens testers. Tailored for the petroleum industry all kinds of liquids can be tested over the wide temperature range of 18 °C to 370 °C using only 2 mL of sample. The full compliance with the latest flash point standard ASTM D7094 brings 100% safety, unrivalled speed [...]
Illumina completes the divestiture of GRAIL
June 24, 2024
GRAIL spin-off complete; GRAIL to begin regular way trading as "GRAL" on June 25 Illumina to issue second quarter 2024 results on August 6; leadership to present Strategy Update on August 13 SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN) today announced the successful completion of the spin-off of GRAIL. This milestone follows the company's previously announced [...]
June 24, 2024
Overview: Thermo Fisher Scientific introduces the Thermo Scientific™ IntelliStack™ Incubator and CO2 Incubator Shakers to help provide accurate, adjustable and reproducible growth conditions for mammalian, bacterial and yeast cultures. The easy-to-use fully integrated shaking solution features an intuitive touchscreen display, large 5-liter capacity and precise control over conditions that improve efficiency and ensure sample security. [...]
Bio-Rad Extends Range of Anti-Biotherapeutic Antibodies to Accelerate Antibody Drug Development
June 24, 2024
Four New Anti-Idiotypic Antibodies and a New Anti-MMAE Antibody Range Support Bioanalytical Assay Development for Preclinical Research and Clinical Trials HERCULES, Calif. — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today launched four new anti-idiotypic antibodies to the following drugs: atezolizumab (Tecentriq), avelumab (Bavencio), [...]
Integrated DNA Technologies Introduces New HIV Panel to Advance Virology Research
June 24, 2024
xGen™ HIV Amplicon Panel provides a single-tube, 2.5-hour workflow designed to enable detection down to 1,000 viral genome copies CORALVILLE, Iowa -- Global genomics solutions provider, Integrated DNA Technologies (IDT), is bringing a new solution to address challenges researchers face in accelerating Human Immunodeficiency Virus (HIV) drug discovery and research. The company announced availability of [...]
June 24, 2024
Collaboration Establishes AGRF as Premier Provider of Dovetail’s Cutting-Edge Genomic Technologies, Boosting Innovation and Access Across Australia and New Zealand SCOTTS VALLEY, CA and MELBOURNE, AUSTRALIA – Dovetail Genomics, a pioneering leader in the development of genomic solutions, today announced a new strategic partnership with Australian Genome Research Facility (AGRF). As Australia’s premier nonprofit organization, AGRF [...]
SOPHiA GENETICS Launches New Residual Acute Myeloid (RAM) Application
June 24, 2024
Novel application supports measurable residual disease (MRD) testing to help monitor cancer and stay ahead of relapse Boston, US and Rolle, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced its new Residual Acute Myeloid (RAM) Application. The new offering expands the company’s comprehensive oncology [...]

